 Les soins à domicile en oncologie pédiatrique; Missotten, Pierre  ; et alConference (2010, October 22) Detailed reference viewed: 25 (0 ULg)  Enfants en et hors traitements oncologiques : analyse comparative de leur qualité de vie et de leur vécu émotionnelMissotten, Pierre ; ; et alPoster (2010, May) Detailed reference viewed: 39 (3 ULg) Perioperative management of a child with von Willebrand disease undergoing surgical repair of craniosynostosis: looking at unusual targets.Maquoi, Isabelle ; Bonhomme, Vincent ; et alin Anesthesia and Analgesia (2009), 109(3), 720-4 We report the successful management of a craniosynostosis repair in a child with severe Type I von Willebrand disease diagnosed during the preoperative assessment and treated by coagulation factor VIII ... [more ▼] We report the successful management of a craniosynostosis repair in a child with severe Type I von Willebrand disease diagnosed during the preoperative assessment and treated by coagulation factor VIII and ristocetin cofactor. Collaboration among the anesthesiologist, the neurosurgeon, the clinical pathologist, and the pediatric hematologist is important for successful management. [less ▲] Detailed reference viewed: 47 (12 ULg) L’Inventaire Systémique de Qualité de Vie pour Enfants (ISQV-E©) : Etude de validationMissotten, Pierre ; ; et alPoster (2008, May) Detailed reference viewed: 34 (1 ULg)Management of diffuse glioma in children: a retrospective study of 27 cases and review of literature.Piette, Caroline ; Deprez, Manuel ; et alin Acta Neurologica Belgica (2008), 108(2), 35-43 Gliomas are the most common CNS tumours in children and present either as circumscribed tumours or diffusely infiltrative neoplasms. Diffuse gliomas develop both in the cerebral hemispheres and the ... [more ▼] Gliomas are the most common CNS tumours in children and present either as circumscribed tumours or diffusely infiltrative neoplasms. Diffuse gliomas develop both in the cerebral hemispheres and the brainstem and have a poor prognosis. Guidelines for the therapy of these tumours are still debated. In this study, we reviewed the clinical features of 27 consecutive patients with diffuse gliomas admitted to the Department of Paediatrics of CHR Citadelle, University of Liege, between 1985 and 2005. We review their clinical presentation, diagnosis, treatment and outcome with reference to the published literature. [less ▲] Detailed reference viewed: 59 (7 ULg)F-18-FDG PET in children with lymphomasDepas, Gisèle ; ; Jerusalem, Guy et alin European Journal of Nuclear Medicine and Molecular Imaging (2005), 32(1), 31-38 Purpose: The aim of this study was to retrospectively evaluate the performance of positron emission tomography (PET) with F-18-fluorodeoxyglucose (F-18-FDG) in children with lymphomas, at various stages ... [more ▼] Purpose: The aim of this study was to retrospectively evaluate the performance of positron emission tomography (PET) with F-18-fluorodeoxyglucose (F-18-FDG) in children with lymphomas, at various stages of their disease. Methods: Twenty-eight children (mean age 12.5 years, 14 girls, 14 boys) with Hodgkin's disease (HD, n=17) or non-Hodgkin's lymphoma (NHL, n= 11) were evaluated. Patients were investigated at initial staging (n=19), early in the course of treatment (n=19), at the end of treatment (n=16) and during long-term follow-up (n=19). A total of 113 whole-body PET studies were performed on dedicated scanners. PET results were compared with the results of conventional methods (CMs) such as physical examination, laboratory studies, chest X-rays, computed tomography, magnetic resonance imaging, ultrasonography and bone scan when available. Results: At initial evaluation (group 1), PET changed the disease stage and treatment in 10.5% of the cases. In early evaluation of the response to treatment (group 2), PET failed to predict two relapses and one incomplete response to treatment. In this group, however, PET did not show any false positive results. There were only 4/75 false positive results for PET among patients studied at the end of treatment (group 3, specificity 94%) or during the systematic follow-up (group 4, specificity 95%), as compared with 27/75 for CMs (specificity 54% and 66%, respectively). Conclusion: F-18-FDG-PET is a useful tool for evaluating children with lymphomas. Large prospective studies are needed to appreciate its real impact on patient management. [less ▲] Detailed reference viewed: 39 (5 ULg)Transmission of chronic myeloid leukemia through peripheral-blood stem-cell transplantation.Baron, Frédéric ; ; Beguin, Yves in New England Journal of Medicine [=NEJM] (2003), 349(9), 913-4 Detailed reference viewed: 7 (4 ULg) |
||
